Invasive methicillin-resistant staphylococcus aureus infections among persons who inject drugs — Six sites, 2005–2016

Morbidity and Mortality Weekly Report

Volumn 67, Issue 22, 2018, Pages 625-628

  Jackson, Kelly A ^a   Bohm, Michele K ^b   Brooks, John T ^c   Asher, Alice ^c   Nadle, Joelle ^d   Bamberg, Wendy M ^e   Petit, Sue ^f   Ray, Susan M ^d   Harrison, Lee H ^g   Lynfield, Ruth ^h   Dumyati, Ghinwa ^d   Schaffner, William ⁱ   Townes, John M ^j   See, Isaac ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Johns Hopkins Bloomberg School of Public Health ^*  (United States)

^e Air Pollution Control Division   (United States)

^f Vanderbilt University School of Medicine ^*  (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h MINNESOTA DEPARTMENT OF HEALTH   (United States)

ⁱ VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; FEMALE; HEALTH SURVEY; HUMAN; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGY; MIDDLE AGED; STAPHYLOCOCCUS INFECTION; SUBSTANCE ABUSE; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; POPULATION SURVEILLANCE; STAPHYLOCOCCAL INFECTIONS; SUBSTANCE ABUSE, INTRAVENOUS; UNITED STATES; YOUNG ADULT;

EID: 85048114379     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: 10.15585/mmwr.mm6722a2     Document Type: Article

References (9)

1. CDC. Annual surveillance report of drug-related risks and outcomes— United States, 2017. Atlanta, Georgia: US Department of Health and Human Services, CDC; 2017. https://www.cdc.gov/drugoverdose/pdf/pubs/2017-cdc-drug-surveillance-report.pdf
2. Jones CM, Logan J, Gladden RM, Bohm MK. Vital signs: demographic and substance use trends among heroin users—United States, 2002–2013. MMWR Morb Mortal Wkly Rep 2015;64:719–25.
3. Peters PJ, Pontones P, Hoover KW, et al.; Indiana HIV Outbreak Investigation Team. HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. N Engl J Med 2016;375:229–39. https://doi.org/10.1056/NEJMoa1515195
4. Zibbell JE, Iqbal K, Patel RC, et al. Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years—Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012. MMWR Morb Mortal Wkly Rep 2015;64:453–8.
5. Keeshin SW, Feinberg J. Endocarditis as a marker for new epidemics of injection drug use. Am J Med Sci 2016;352:609–14. https://doi.org/10.1016/j.amjms.2016.10.002
6. Lewer D, Harris M, Hope V. Opiate injection-associated skin, soft tissue, and vascular infections, England, UK, 1997–2016. Emerg Infect Dis 2017;23:1400–3. https://doi.org/10.3201/eid2308.170439
7. Ronan MV, Herzig SJ. Hospitalizations related to opioid abuse/ dependence and associated serious infections increased sharply 2002–2012. Health Aff (Millwood) 2016;35:832–7. https://doi.org/10.1377/hlthaff.2015.1424
8. Dantes R, Mu Y, Belflower R, et al.; Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med 2013;173:1970–8.
9. Lansky A, Finlayson T, Johnson C, et al. Estimating the number of persons who inject drugs in the United States by meta-analysis to calculate national rates of HIV and hepatitis C infections. PLoS One 2014;9:e97596. https://doi.org/10.1371/journal.pone.0097596